Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45.88 USD | +3.36% | +7.57% | +106.02% |
Evolution of the average Target Price on Agios Pharmaceuticals, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Agios Pharmaceuticals, Inc.
Goldman Sachs | |
RBC Capital Markets | |
JPMorgan Chase | |
Piper Sandler | |
SVB Securities LLC | |
HC Wainwright | |
SVB Leerink | |
Canaccord Genuity | |
BofA Securities | |
Raymond James | |
Barclays | |
J.P. Morgan Chase |
EPS Revisions
- Stock Market
- Equities
- AGIO Stock
- Consensus Agios Pharmaceuticals, Inc.